IRIS
GABRIELLI, Armando
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.510
EU - Europa 6.918
AS - Asia 2.453
SA - Sud America 436
AF - Africa 183
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 7
Totale 20.522
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.460
UA - Ucraina 1.350
IT - Italia 1.039
SE - Svezia 881
DE - Germania 771
RU - Federazione Russa 751
IE - Irlanda 740
SG - Singapore 711
TR - Turchia 470
DK - Danimarca 464
CN - Cina 462
HK - Hong Kong 441
BR - Brasile 409
FI - Finlandia 342
KR - Corea 243
FR - Francia 233
GB - Regno Unito 198
CI - Costa d'Avorio 101
MA - Marocco 72
IN - India 51
BE - Belgio 38
CA - Canada 33
PL - Polonia 26
AT - Austria 18
NL - Olanda 17
EU - Europa 14
JP - Giappone 14
RS - Serbia 13
IQ - Iraq 10
AR - Argentina 9
MX - Messico 9
ES - Italia 8
VN - Vietnam 8
PK - Pakistan 7
BD - Bangladesh 6
AU - Australia 5
VE - Venezuela 5
CO - Colombia 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
EC - Ecuador 3
EE - Estonia 3
EG - Egitto 3
JM - Giamaica 3
JO - Giordania 3
TN - Tunisia 3
UZ - Uzbekistan 3
ZA - Sudafrica 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CL - Cile 2
DO - Repubblica Dominicana 2
IR - Iran 2
LB - Libano 2
LT - Lituania 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PA - Panama 2
PH - Filippine 2
PS - Palestinian Territory 2
TW - Taiwan 2
UY - Uruguay 2
BG - Bulgaria 1
BY - Bielorussia 1
HR - Croazia 1
IL - Israele 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PT - Portogallo 1
SI - Slovenia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 20.522
Salva come PNG Salva come JPEG
Città #
Chandler 1.447
Jacksonville 1.406
Fairfield 836
Dublin 738
Boardman 678
Ashburn 630
Wilmington 538
Hong Kong 437
Woodbridge 391
Houston 354
Singapore 343
Seattle 333
New York 331
Centro 323
Des Moines 309
Lawrence 295
Princeton 295
San Mateo 294
Cambridge 231
Ann Arbor 224
Moscow 167
Munich 134
The Dalles 128
San Diego 110
Beijing 103
Abidjan 100
Helsinki 84
Turin 67
Los Angeles 52
London 46
Pune 44
Guangzhou 38
Washington 36
Brussels 35
Marche 35
Redmond 35
Ancona 33
São Paulo 33
Shanghai 31
Turku 30
Dallas 28
Norwalk 28
Nuremberg 24
Jesi 22
Wuhan 21
Milan 20
Porto 20
Jiaxing 19
Auburn Hills 18
Izmir 17
Rome 16
Rio de Janeiro 15
Ottawa 14
Belgrade 13
Falls Church 12
Kilburn 12
Castelfidardo 11
Belo Horizonte 10
Iesi 10
Porto Alegre 10
Shenzhen 10
Chicago 9
Jinhua 9
Santa Clara 9
Bologna 8
Boston 8
Yiwu 8
New Bedfont 7
Southwark 7
Brescia 6
Curitiba 6
Dong Ket 6
Hanover 6
Montréal 6
Ostra 6
San Giorgio A Cremano 6
Terni 6
Tokyo 6
Tolentino 6
Toronto 6
Vienna 6
Wuxi 6
Brasília 5
Brisbane 5
Charlotte 5
Civitanova Marche 5
Comunanza 5
Florence 5
Jyväskylä 5
Nanjing 5
Nürnberg 5
Osasco 5
Prescot 5
San Benedetto Del Tronto 5
San Francisco 5
Sassoferrato 5
Seoul 5
Squinzano 5
Taranto 5
Torre Annunziata 5
Totale 12.357
Salva come PNG Salva come JPEG
Nome #
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 226
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease 143
Multicenter validation of the DETAIL questionnaire for the screening of spondyloarthritis in patients with inflammatory bowel diseases 132
Induction of Scleroderma Fibrosis in Skin-Humanized Mice by Administration of Anti−Platelet-Derived Growth Factor Receptor Agonistic Autoantibodies 125
Plasma free hemoglobin and microcirculatory response to fresh or old blood transfusions in sepsis 119
Epitope specificity determines pathogenicity and detectability of anti-platelet-derived growth factor receptor α autoantibodies in systemic sclerosis 117
La terapia con immunoglobuline endovena nelle malattie autoimmuni 115
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies 114
Erratum: Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance [Radiol med, DOI 10.1007/s11547-014-0419-7] 112
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 111
Adalimumab modulates angiogenesis in psoriatic skin 110
Computed tomography assessment of evolution of interstitial lung disease in systemic sclerosis: Comparison of two scoring systems 110
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 108
Agonistic anti-PDGF receptor autoantibodies from patients with systemic sclerosis impact human pulmonary artery smooth muscle cells function in vitro 106
Disease course in patients with systemic autoimmune diseases: insights on the safety of immunosuppression during the SARS-CoV-2 outbreak in Italy 106
Cardiac involvement in polymyositis and dermatomyositis 105
Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic 104
Biomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet Needs 104
Decreased serum levels of the inflammaging marker miR-146a are associated with clinical response to tocilizumab in COVID-19 patients 103
Piascledine modullates the production of VEGF and TIMP-1 and reduces the invasiveness of rheumatoid arthritis synoviocytes 102
Global longitudinal strain measured by speckle tracking identifies subclinical heart involvement in patients with systemic sclerosis 102
The Exaggerated Collagen Expression in Gvhd-Fibroblasts Is Effectively Inhibited By Therapeutic Concentration of Nilotinib 101
Characterization of binding and quantification of human autoantibodies to PDGFRα using a biosensor-based approach 101
Cognitive and cerebral hemodynamic impairment in scleroderma patients 99
B CELL RECEPTOR EDITING IN SCLERODERMA PATIENTS GENERATES PATHOGENIC ANTI-PDGFR AUTOANTIBODIES 99
Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice 99
AIRE gene polymorphisms in Systemic Sclerosis associated with autoimmune thyroiditis 98
c-myb but not B-myb upregulates a1(I) and a2(I) collagen genes in fibroblasts 97
Biosensor-based Binding Assay for Platelet-Derived Growth Factor Receptor-α Autoantibodies in Human Serum 97
Certolizumab pegol for the treatment of psoriasis 97
Long lasting biological effects of PDGFR agonistic auto-antibodies in scleroderma 96
A randomized controlled trial of Rituximab for the treatment of severe cryoglobulinemic vasculitis. 95
Subcutaneous IgG in the Myositis Spectrum Disorders 95
Systemic sclerosis (scleroderma) and cancer risk: Systematic review and meta-analysis of observational studies 95
Comment on 'Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?' 95
Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK 1/2. Amplification of ROS and Ras in systemic sclerosis fibroblasts 94
Aseptic inflammation of prosthetic knee in a patient affected by rheumatoid arthritis 94
Clinical and patient reported outcomes of the multidisciplinary management in patients with inflammatory bowel disease-associated spondyloarthritis 94
Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis 94
c-MYB transactivates the alpha 2(I) collagen gene. 93
Ha-Ras stabilization mediates pro-fibrotic signals in dermal fibroblasts. 92
Microcirculatory effects of the transfusion of leukodepleted or non-leukodepleted red blood cells in patients with sepsis: a pilot study. 91
Osservazione di una nuova mutazione puntiforme del gene p53 nel seminoma tipico del testicolo: descrizione di un caso 90
Assessment of gastrointestinal involvement in scleroderma. 90
c-myb proto-oncogene is expressed by quiescent fibroblasts and unlike B-myb gene does not correlate with proliferation 90
Identification of a novel human DRB1*13 allele by sequence-based DRB typing. 89
Successful treatment of a Caucasian case of multifocal Castleman¿s disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report 89
BIOLOGIC THERAPY IN INFLAMMATORY AND IMMUNOMEDIATED ARTHRITIS: SAFETY PROFILE 87
A reactive Oxygen species -mediated loop mantains increased expression of NADPH oxidases 2 and 4 in skin fibroblasts from patients with systemic sclerosis 87
Chronic hepatitis E in a patient treated with rituximab and mycophenolate mofetil for Sjögren's syndrome 87
A novel iloprost administration method with portable syringe pump for the treatment of acral ulcers and Raynaud's phenomenon in systemic sclerosis patients. A pilot study (ILOPORTA). 87
Subcutaneous immunoglobulin in inflammatory myopathies: efficacy in different organ systems 87
Scleroderma. 86
Characterization of the c-Myb-responsive region and regulation of the human type I collagen α2 chain gene by c-Myb 86
Pathogenic autoantibodies in systemic sclerosis 86
Subcutaneous immunoglobulin in polymyositis and dermatomyositis: a novel application. 86
Ha-Ras/ERK1-2 pathway is responsable for oxygen species generation by scleroderma skin fibroblasts 86
ALTERATIONS OF ROS PATHWAYS IN SCLERODERMA BEGIN AT STEM CELL LEVEL 86
The DETection of Arthritis in Inflammatory boweL diseases (DETAIL) questionnaire: development and preliminary testing of a new tool to screen patients with inflammatory bowel disease for the presence of spondyloarthritis 86
Sclerostin and Antisclerostin Antibody Serum Levels Predict the Presence of Axial Spondyloarthritis in Patients with Inflammatory Bowel Disease 86
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD 85
Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study 85
The risk of non-Hodgkin's lymphoma in coeliac disease: a case-control, multicentre study 84
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 84
Mapping and predicting mortality from systemic sclerosis 84
Effect of Adalimumab Therapy on Both Gastrointestinal and Articular Inflammation at 6 Months in Patients Affected by Enteropathic Spondyloarthritis: Preliminary Results from a Monocentric Prospective Observational Study 84
A novel HLA-Cw*6 allele Cw*160102, identified by cloning and sequencing. 83
Patient Reported Outcomes and Quality of Life in a Cohort of Patients Affected by Entheropathic Spondyloarthritis: Preliminary Results from a Monocentric Prospective Observational Study 83
Intracellular free radical production by peripheral blood T lymphocytes from patients with systemic sclerosis: Role of NADPH oxidase and ERK1/2 83
Biologics in inflammatory immune-mediated systemic diseases 83
History and scientific production of clinica medica and clinica ematologica in ancona 83
WIF1, A WNT PATHWAY INHIBITOR, IS SILENCED IN SYSTEMIC SCLEROSIS BY DNA DAMAGE: A MECHANISM LINKING DNA DAMAGE TO WNT AND FIBROSIS 82
Antibodies to mycobacterial 65 kDa heat shock protein in systemic sclerosis (scleroderma). 82
Reduced type I collagen gene expression by skin fibroblasts of patients with systemic sclerosis after one treatment course with rituximab 82
Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study 82
Mycophenolate mofetil-induced colitis in a patient with systemic sclerosis 82
Activation in vitro of scleroderma skin fibroblasts is sustained by increased generation of free radicals through the NADPH-oxidase pathway. 81
Subclinical Cardiac Dysfunction in Polymyositis and Dermatomyositis: A Speckle-tracking Case-control Study 81
Biologics in inflammatory and immunomediated arthritis 81
A painful diagnosis 81
Are HLA class II and immunoglobulin constant region genes involved in the pathogenesis of mixed cryoglobulinemia type II after hepatitis c virus infection? 80
Abnormal cerebrovascular reactivity and cognitive impairment in systemic sclerosis 80
TOSSE STIZZOSA: PRESENTAZIONE ATIPICA DI UNA VASCULITE DEI GRANDI VASI 80
C-myb proto-oncogene is expressed by quiescent scleroderma fibroblasts and, unlike B-myb gene, does not correlate with proliferation 80
Traiano: Educational (but not only) opportunity for Master Students 80
Influence of TYK2 in systemic sclerosis susceptibility: A new locus in the IL-12 pathway 80
Low-dose Oral Imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide. A phase II pilot study 80
Detection of typical and atypical bovine spongiform encephalopathy and scrapie prion strains by prion protein motif-grafted antibodies. 80
Reduction of bcl-2 in T-cells during immunosuppressive therapy in patients with severe juvenile onset systemic lupus erithematosus 79
Subcutaneous immunoglobulins in polymyositis and dermatomyositis: a novel application. 79
Acute myocarditis associated with adenoviral infection in a patient with scleroderma 79
Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with systemic sclerosis 79
MULTICENTER VALIDATION OF THE DETECTION OF ARTHRITIS IN INFLAMMATORY BOWEL DISEASES (DETAIL) QUESTIONNAIRE FOR THE SCREENING OF SPONDYLOARTHRITIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES 79
Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis 79
Recommendations for the management of biofilm: a consensus document. 79
Deflazacort moduletes the fibrynolitic pattern and reduces uPA-dependent chemoinvasion and proliferation in rheumatoid arthritis synoviocytes 78
Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinaemia. 78
A validation study of the Simple Psoriatic Arthritis Screening (SiPAS) questionnaire to screen psoriasis patients for psoriatic arthritis 78
Agonistic antibodies in systemic sclerosis 78
Immunohistochemical localization of intracellular and extracellular associated TGFb in the skin of patients with systemic sclerosis (scleroderma) and primary Raynaud's phenomenon 77
Totale 9.298
Salva come PNG Salva come JPEG
Categoria #
all - tutte 116.206
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 116.206
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020456 0 0 0 0 0 0 0 0 0 0 86 370
2020/20213.918 184 416 553 39 514 195 373 228 433 337 436 210
2021/20222.100 109 537 62 131 17 106 77 159 126 129 201 446
2022/20234.169 380 433 343 353 306 688 13 279 1.009 38 218 109
2023/20242.235 419 47 135 345 350 487 37 56 13 68 21 257
2024/20253.763 425 425 197 43 205 118 481 163 1.051 329 326 0
Totale 20.932